Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Combined With Remazolam vs Propofol in Pediatric Gastroscopy
NCT07748884Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and remimazolam in gastroscopy (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Incidence of Respiratory Adverse Events During Anesthesia. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
esketamineremimazolam
03
Conditions
gastroscopy
Beyond the preview
Go deeper on NCT07748884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07748884.